Showing results (31-40 of 49) with videos related to
Sort By:
Pageof 5
Nucleic Acids Research|January 10, 2003
Enlarged FAMSBASE: protein 3D structure models of genome sequences for 41 speciesAkihiro Yamaguchi, Mitsuo Iwadate, Ei-ichiro Suzuki, et al.Proteins|September 27, 2007
Fams-ace: a combined method to select the best model after remodeling all server modelsGenki Terashi, Mayuko Takeda-Shitaka, Kazuhiko Kanou, et al.Biochemical and Biophysical Research Communications|June 23, 2015
Development of novel hepatitis B virus capsid inhibitor using in silico screeningMichiyo Hayakawa, Hideaki Umeyama, Mitsuo Iwadate, et al.Biochemical and Biophysical Research Communications|December 3, 2014
Discovering novel direct acting antiviral agents for HBV using in silico screeningYoshiki Murakami, Michiyo Hayakawa, Yoshihiko Yano, et al.Thrombosis and Haemostasis|February 23, 2002
Substitution of Gly-548 to Ala in the substrate binding pocket of prothrombin Perijá leads to the loss of thrombin proteolytic activityOsamu Sekine, Teruko Sugo, Kazuyoshi Ebisawa, et al.Microbiology (Reading, England)|January 30, 2007
Identification of amino acid residues of Salmonella SlyA that are critical for transcriptional regulationNobuhiko Okada, Yorie Oi, Mayuko Takeda-Shitaka, et al.Translational Oncology|November 3, 2017
Retrospective Proteomic Analysis of a Novel, Cancer Metastasis-Promoting RGD-Containing PeptideMichiyo Tsuru, Michio Sata, Maki Tanaka, et al.Journal of Bacteriology|July 31, 2007
Topology of AspT, the aspartate:alanine antiporter of Tetragenococcus halophilus, determined by site-directed fluorescence labelingKei Nanatani, Takashi Fujiki, Kazuhiko Kanou, et al.Scientific Reports|January 9, 2020
Development of a novel anti-hepatitis B virus agent via Sp1Michiyo Hayakawa, Hideaki Umeyama, Mitsuo Iwadate, et al.Scientific Reports|April 22, 2020
Author Correction: Development of a novel anti-hepatitis B virus agent via Sp1Michiyo Hayakawa, Hideaki Umeyama, Mitsuo Iwadate, et al.Pageof 5